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Summary
Objectives To examine the prevalence of risk factors for diabetes and
its complications in the Co-operation Council of the Arab States of the Gulf
(GCC) region.
Design Systematic review.
Setting Co-operation Council of the Arab States of the Gulf (GCC) states
(United Arab Emirates, Bahrain, Saudi Arabia, Oman, Qatar, Kuwait).
Participants Residents of the GCC states participating in studies on
the prevalence of overweight and obesity, hyperglycaemia, hypertension
and dyslipidaemia.
Main outcome measures Prevalences of overweight, obesity and
hyperglycaemia, hypertension and hyperlipidaemia.
Results Forty-ﬁve studies were included in the review. Reported
prevalences of overweight and obesity in adults were 25–50% and
13–50%, respectively. Prevalence appeared higher in women and to
hold a non-linear association with age. Current prevalence of impaired
glucose tolerance was estimated to be 10–20%. Prevalence appears to
have been increasing in recent years. Estimated prevalences of
hypertension and dyslipidaemia were few and used varied deﬁnitions
of abnormality, making review difﬁcult, but these also appeared to be high
and increasing,
Conclusions There are high prevalences of risk factors for diabetes
and diabetic complications in the GCC region, indicative that their current
management is suboptimal. Enhanced management will be critical if
escalation of diabetes-related problems is to be averted as
industrialization, urbanization and changing population demographics
continue.
DECLARATIONS
Competing interests
None declared
Funding
This study was
supported by
sponsorship
provided to Layla
Alhyas by the United
Arab Emirates
Ministry of Research
and Higher
Education, Abu
Dhabi. The funders
had no role in study
design, data
collection and
analysis, decision to
publish, or
preparation of the
manuscript
Ethical approval
Not applicable
Guarantor
LA
Contributorship
LA created and
revised the research
strategy; LA and
AMcK selected and
assessed the quality
J R Soc Med Sh Rep 2011;2:55. DOI 10.1258/shorts.2011.011019
RESEARCH
1Introduction
The increasing prevalence of diabetes mellitus,
particularly type 2 diabetes mellitus, is well docu-
mented.
1 Type 2 diabetes is currently estimated to
account for over 90% of the global diabetes
burden.
2 Together with similar trends in other
non-communicable diseases, it leads to risks not
only for individuals, but for health systems,
social systems, and state economies. This risk is
in part to do with an anticipated relatively dra-
matic rise in countries with relatively young
populations, and still developing economic
infrastructure, as they undergo the predicted
increases in prevalence of diabetes associated
with changes in lifestyle and economic develop-
ment, and population growth. Even when based
on changes in population size and demography
alone,
3 the highest predicted future increases are
expected in the International Diabetes Federa-
tion’s ‘African’ region (estimated 98.1% increase
2010–2030), followed by the ‘Middle East-North
Africa’ region (estimated 93.9% increase 2010–
2030
4). The Middle East-North Africa region
already has some of the highest rates of diabetes
in the world. The countries of the Co-operation
Council for the Arab States of the Gulf (GCC)
include those currently ranked 2, 3, 5, 7 and 8 for
diabetes prevalence among the 216 countries for
which data are available.
4
This high prevalence in the GCC states is
associated with higher prevalences of risk factors
for type 2 diabetes in this region. The International
Diabetes Federation suggests the following as risk
factors for type 2 diabetes: age, obesity, family
history, physical inactivity, race and ethnicity,
and gestational diabetes. Of the modiﬁable risk
factors, physical inactivity appears to have been
surprisingly little studied in this region, although
it is likely to be correlated with overweight and
obesity, which have been relatively well studied.
We aimed to review the prevalence of over-
weight and obesity in the GCC region. We also
aim to review the prevalence of potentially ‘pre-
diabetic’ hyperglycaemia (measured either as
impaired fasting glycaemia, impaired glucose tol-
erance or raised random glucose). We also exam-
ined hypertension and dyslipidaemia, which are
risk factors for adverse outcomes in people with
diabetes.
5–7 Diabetes is complicated by various
micro- and macro-vascular conditions and
people with metabolic syndrome – a collective of
obesity, insulin resistance, dyslipidaemia, hyper-
tension and hyperglycaemia
8–12 – have a rela-
tively higher prevalence of cardiovascular
disease than those without.
13 Due to the hetero-
geneity of studies identiﬁed on preliminary
searching, there was no anticipated meta-analysis.
Methods
Review question
A literature search was used to identify material
relevant to the following review question: What
are the prevalences of overweight and obesity,
hyperglycaemia, hypertension and dyslipidaemia
in the GCC region?
Search strategy
We developed a systematic review protocol (avail-
able from the authors on request) using the Centre
for Reviews and Dissemination guidelines.
14
Medline and Embase were searched separately
on 15 July 2009 and the search was repeated on
03 July 2010 (via Dialog and Ovid, respectively;
1950 to July week 1 2010, and 1947 to July 2010)
using terms identiﬁed from PICOS deconstruction
of the above review questions, and database- and
manually- derived alternatives (Appendix 1).
The search strategy wastrialled, reviewed by inde-
pendent professional colleagues (IW, KP) and
updated before use. Further relevant studies
were identiﬁed by searching the reference lists of
the database-derived papers, contacting expert
investigators, screening conference proceedings,
citation searching and hand searching the Inter-
national Journal of Diabetes and Metabolism and
the Saudi Medical Journal, for the periods 1993–
2009 and 2000–2010, respectively.
Selection of studies
The search yielded 1331 studies. The titles and
abstracts were evaluated by one reviewer to deter-
mine eligibility for full screening. All studies
wherein overweight, obesity, body mass index
(BMI), hyperglycaemia, hypertension and dyslipi-
daemia were investigated were eligible for
inclusion. No limitations on publication type,
publication status, study design or language of
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Reviewer
Paramjit Gillpublication were imposed. However, we did not
include secondary reports such as review articles
without novel data synthesis. The inclusion cri-
teria required that the study population be of a
GGC country, but otherwise all ages, sexes and
ethnicities were included, resident and expatriate
populations, urban and rural, of all socioeconomic
and educational backgrounds. Studies of general,
working, young, student, healthcare attending,
and other populations were included. We did not
specify diagnostic criteria for the studied con-
ditions, but incorporated them into our data
synthesis.
A total of 1331 studies were identiﬁed. The full
texts of these studies were each considered by two
reviewers (LA and McK). All studies of diabetic
populations were excluded,
15–17 and studies
wherein people with diabetes had been excluded
from the study population were excluded.
18,19
Further exclusions were made on the basis that
the studies were:
￿ Reviews without relevant novel synthesis;
20,21
￿ Of a type 1 diabetes population;
22
￿ Of a population outside the GCC region;
23
￿ Reported trends in prevalence, without provid-
ing prevalence rates per se;
24,25
￿ Duplications of data contained in other
studies.
26
The selection process is summarized in Figure 1.
Data extraction/quality
assessment
The data extracted from each study included data
relating to: (1) methods (study design, recruit-
ment, measurement tools, analysis); (2) partici-
pant characteristics; (3) setting; and (4) outcomes
(those observed, their deﬁnitions, results of analy-
sis). Study quality was assessed using a checklist
adapted from the Centre for Reviews and Dis-
semination guidelines.
14 As the identiﬁed studies
were relatively few and heterogeneous, no study
was excluded on the basis of quality alone;
rather the assessment was used to inform syn-
thesis. Data extraction was performed, in dupli-
cation, by two reviewers (LA and AM), and
disagreement regarding any study eligibility was
Figure 1
Flow chart of study selection process
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3resolved through consensus and seeking the
opinion of the third reviewer (AM).
Data synthesis
Data synthesis included summarizing the results
of the data extraction process, considering the
strength of evidence relating to various questions
formulated a priori (see the Results section), and
examination of results inconsistent with our
formed proposals. In the cases of hypertension
and dyslipidaemia, synthesis was limited by the
number of studies identiﬁed, and in these cases
description and discussion sufﬁces.
Results
Forty-ﬁve studies (43 papers) relating to risk
factors and their prevalence were identiﬁed for
review. All papers identiﬁed were journal articles
published between 1987 and 2010. Five studies
were carried out (where reported) and/or pub-
lished in the late 1980s, 23 in the 1990s, and 15 in
the last 10 years. Studies of various 20 Saudi,
24–46,
seven Kuwaiti,
47–50 three Bahraini,
51–53 eight
Emirati,
54–60 four Omani
61–64 and one Qatari
65
populations were included. All were cross-
sectional studies; 23 of the general population,
seven of primary care populations, four of school-
children, three of students, one of a young popu-
lation, ﬁve of working populations. Women were
exclusively studied in ﬁve cases, men in six.
Sample size ranged from 215 to 25,337.
In addition to examining the prevalence of the
particular risk factors in the GCC states, we were
interested in the following:
(1) Trends in prevalence across time;
(2) Differences by country;
(3) Trends in prevalence associated with age;
(4) Sex differences;
(5) Location (urban/rural) differences;
(6) Prevalence in children.
Only in the cases of overweight and obesity, and
hyperglycaemia were study numbers sufﬁcient
that reasonable conjecture regarding subgroups
could be made. They are considered separately,
for each risk factor, below.
Obesity/overweight
Thirty-three studies addressed the prevalence of
overweight/obesity (Table 1).
Overweight and effect of date and country
The reported prevalence rates of overweight (BMI
25 to <30) in adults ranged from 26.3–48% in men,
and 25.2–35% in women. Although higher values
are displayed in Table 1, they have been scaled
down for/omitted from comparison as either the
deﬁnition of overweight used included the
typical deﬁnition of obesity, or the prevalence
was given only by age group, allowing the possi-
bility that similarly high ﬁgures were masked in
the age-non-speciﬁc data of other studies. A
lower value has also been omitted where the
study population was particularly young.
54
Within these ranges, the data were fairly even
distributed between the limits, and reported
sex-non-speciﬁc prevalences were also consistent
with these ﬁgures. The data showed no obvious
trends or anomalies by date or country, although
the data from Oman (two studies, reporting com-
bined overweight/obesity rates) suggest preva-
lence there may be relatively low.
Obesity and effect of date
and country
The reported general prevalence rates of obesity
(deﬁned as BMI ≥ 30) in adults ranged from
13.05–37% in men, and 16–49.15% in women
(again a lower value has been omitted where
the study population was particularly young
54).
As for the overweight data, the reported
sex-non-speciﬁc data are consistent with these
ﬁgures, and potentially excepting the Omani
data, show no obvious trends or anomalies by
date or country.
Obesity and overweight and age
Age as a potential predictor of prevalence of over-
weight/obesity was considered in eight studies (of
adult populations), and the results were tested for
signiﬁcance in two cases. These latter studies
demonstrated correlation between overweight/
obesity and age,
36 and a signiﬁcantly higher
mean BMI in a 45–54-year age group versus a
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855–64-year age group.
49 Similarly, all remaining
studies indicated that prevalence increased with
age to a threshold level (variably between 30–40
and 50–60 years (potentially younger in women)
after which it began to fall, or ﬂuctuate.
27,33,47,48
Obesity and overweight and sex
Most studies reported prevalence rates by sex, but
only four tested fordifferences. Of these four, in all
cases but one, BMI/prevalence of obesity and
overweight was higher in women,
35,54,60 and
where overweight was higher in men,
36 the com-
bined prevalence of overweight/obesity remained
higher in women. In the remaining studies, preva-
lence of obesity, and the combined prevalence of
overweight/obesity was again always higher in
women, although in some cases the ‘difference’
was slight.
Obesity and overweight and residential
environs
Six studies considered prevalence in urban versus
rural populations. In three, mean BMI was found
to be signiﬁcantly higher in rural popu-
lations.
31,33,34 In a further two studies, prevalence
of both overweight and obesity were signiﬁcantly
lower in rural regions.
29,30 This trend (with one
subgroup exception – female obesity) was also
observed where signiﬁcance of differences was
unclear.
51
Obesity and overweight in national/
expatriate populations
Onlyone study considered prevalences in national
versus expatriate populations. This reported that
the combined prevalence of obesity and over-
weight was higher in Kuwaitis versus non-
Kuwaitis.
66
Obesity and overweight in children
In keeping with the association with age, preva-
lences in children/young people (<20 years) are
lower than those in adult populations. However,
there is a greater indication that prevalences in
the younger populations are increasing. Single
ﬁgure prevalences were reported until around
2000, and have not been observed since. The
most recent reports (suggesting prevalences of
combined overweight and obesity >30%) provide
rates comparable to those in adults. Although
less considered, there is again evidence for
higher prevalences with increasing age in these
relatively young populations,
47,56,67 in urban
areas
57 and in girls.
39,57
Hyperglycaemia
Seventeen studies
28,29,40–45,49,50,53,59,61,63–65 reported
on the prevalence of hyperglycaemia, 12 studies as
impaired glucose tolerance,
28,29,40–44,53,63–65 three
studies as impaired fasting glucose
45,59,61 or a
high random capillary glucose (>10 mmol/L).
49,50
A summary is provided in Table 2. Generally,
impaired glucose tolerance was deﬁned as
venous plasma glucose ≥7.8 and <11.1 mmol/L
2 h post glucose loading. Where the World
Health Organization 1980 criteria were used,
however, the impaired glucose tolerance would
be deﬁned as venous plasma glucose 8.0 and
11.0 mmol/L 2 h post glucose loading, and the
study of Al-Moosa et al.
62 involved capillary
whole blood rather than venous plasma samples
(Table 2). Impaired fasting glucose was consist-
ently deﬁned as a fasting venous plasma glucose
≥6.1 and <7.0 mmol/L. The studies of random
capillary blood glucose and impaired fasting
glucose are so few that interpretation is difﬁcult.
Additionally, the random glucose measurement
ﬁgures are likely to include instances of transi-
ent/‘stress’ hyperglycaemia. Nevertheless, both
are potentially consistent with the impaired
glucose tolerance results.
Prevalence of impaired glucose tolerance
and age
Broadly speaking, the relatively comprehensive
study of impaired glucose tolerance is suggestive
of a recent and ongoing increase in prevalence,
with the latest published ﬁgures suggesting rates
of perhaps 10–20% in the adult population.
Although there are some inconsistent ﬁgures
(Table 2), we consider that these could be
accounted for by a combination of changes in
prevalence across time and the ages of the
studied populations. The studies of El-Hazmi
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Prevalences of overweight, obesity, hyperglycaemia, hypertension and dyslipidaemia in the Gulf
11et al.
44 in particular reports an inconsistently low
ﬁgure, but their sample was 39.1% children and
the authors report a signiﬁcantly higher preva-
lence with increasing age, although we could not
access the full data and the statistics were not
described. Similarly, the other relatively young
populations are those wherein reported preva-
lences are relatively low. Furthermore, of all
studies reviewed (including those of random
blood glucose and impaired fasting glucose), ﬁve
considered the effect of age on prevalence.
42–
44,49,50 All found the prevalence was higher with
advancing age, and in all cases where tested
(three cases), the relationship was found to be
signiﬁcant.
43,49,50
Prevalence of hyperglycaemia by country
There was no obvious discrepancy in prevalence
by country, but the number of studies available
prohibited a reasonable comparison.
Prevalence of hyperglycaemia by sex
Thirteen studies reported differential prevalence
rates by sex, although not all considered the
strength of sex differences. The majority of
studies (10) suggested a higher prevalence in
women.
29,41–43,45,46,53,59,63,65 Two demonstrated a
signiﬁcantly higher prevalence.
41,59 Conversely,
two studies
50,61 showed a higher prevalence in
men (one signiﬁcantly so
61), and one demon-
strated no sex difference.
45
Urban/rural residence and prevalence
of hyperglycaemia
Only one study reported prevalence according to
urban versus rural residence.
29 Prevalence was
higher in urban areas.
Prevalence of hyperglycaemia
by residential status
No studies reported on effects of ethnicity, or on
the prevalence of hyperglycaemia in national
versus expatriate populations.
Hypertension and dyslipidaemia
Only few of the identiﬁed studies investigated the
prevalence of hypertension
34,46,59,60,62,65 and dysli-
pidaemia.
34,49,62,66 Moreover, variable or ill-
deﬁned deﬁnitions of the diagnosis were used in
each case.
Hypertension
We identiﬁed eight studies that included an
assessment of hypertension.
30,34,46,59,60,62,65,66 The
deﬁnitions of hypertension employed ranged
from ≥140/≥90 mmHg to >160/95 mmHg, and
variably included those on antihypertensive
medication. Additionally, one study
34 depended
upon a previous (undescribed) diagnosis.
Reported rates of hypertension ranged from 6.6–
33.6%. Potentially prevalence has been increasing
since 1993–1994 (when the ﬁrst identiﬁed
studies were undertaken).
Dyslipidaemia
Dyslipidaemia was considered in six
studies.
34,46,49,50,62,65 Dyslipidaemia was deﬁned as:
cholesterol ≥5.2 mmol/L, cholesterol >5m m o l /L,
high density lipoprotein <1.0 mmol/L, low
density lipoprotein >4.1 mmol/L, triglycerides
≥2.3 mmol/L, or a previous (undescribed) diagno-
sis. Reported rates of dyslipidaemia ranged from
2.7–51.9%. This relatively large range is potentially
partially due to increasing rates across recent
years, to consideration of different aspects of the
lipid proﬁlein different studiesand to differing deﬁ-
nitions of abnormality. Additionally, in the study
reporting the very lowest prevalence,
34 diagnosis
was established by ‘previous diagnosis’ alone, and
thus allowed no assessment of the extent of undiag-
nosed cases.
Discussion
We found the prevalence of overweight to be 25–
50%, obesity 10–50%, relatively high in women
and higher with advancing age to threshold
levels between 30–40 and 50–60 years. Prevalence
was also found to be high in children, and
appeared to be increasing in this group. We esti-
mated, from relatively recent reports, the preva-
lence of hyperglycaemia in adults (using
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12impaired glucose tolerance as the outcome
measure) to be approximately 10–20%. Prevalence
of hyperglycaemia appears to have been increas-
ing across recent years, and higher prevalence
again showed an association with advancing age
and female sex. There has been relatively little
research of the prevalences of hypertension and
dyslipidaemia in the GCC region and a lack of
consistency in deﬁnitions used for study. Accord-
ingly, estimates of prevalence vary: between 6.6–
33.6% for hypertension, between 2.7–51.9% for
dyslipidaemia, and it is unclear what additional
factors may have impacted on these ranges.
Potentially,theprevalencesofhypertensionand
dyslipidaemia are increasing, which would be in
keeping with a more widespread trend.
68–70 The
increasing prevalence of hyperglycaemia is simi-
larly in keeping with trends reported elsewhere.
By contrast, we observed no obvious temporal
trend in prevalence of overweight and obesity in
adult populations, which is not in keeping with
reports from elsewhere, and despite a relatively
well established association with diabetes (both
epidemiologically and pathophysiologically
1,71–73)
and pathophysiologically. Importantly, though,
particular authors have noted a rising prevalence
within the relatively well controlled environments
of their own studies,
47,48 and several of the
reviewed studies did demonstrate correlation
between BMI, and overweight and obesity, and
diabetes or blood glucose concentration.
28,35,50
Moreover, the observed prevalence of overweight
and obesity by age, increasing with advancing
age until a plateau or decline in middle and older
age, is suggestive that overweight and obesity
may be an important risk factor for diabetes.
We noted differences in the patterns of spread
of diabetes and obesity and overweight in the
GCC region. For example, the observed bias of
obesity and overweight to the female population
is not obviously replicated in the population dis-
tribution of diabetes (unpublished data), demon-
strating that additional aetiological factors may
hold important roles in the current expansion of
the diabetes problem.
Implications
We consider the need for further study to identify
the major contributory factors to the current
diabetes problem in the GCC region, and of
factors such as hypertension and dyslipidaemia
that compound the risks of diabetes, an important
outcome of our review. The limited number and
heterogeneity of existing studies pose difﬁculties
for targeting, designing and developing potential
management strategies. The relatively high levels
of hyperglycaemia, and obesity and overweight
(and potentially of hypertension and dyslipidae-
mia) observed – and their possible rising preva-
lences – are indicative that current management
is insufﬁcient. The reviewed data are suggestive
that age and urban residence may be risk factors
for, at least, overweight/obesity and hyperglycae-
mia. Enhanced management is thus crucial to
prevent escalation of the problems as urbanization
and changing population demographics continue.
It would be useful to determine that the situ-
ation is similar across the various GCC states.
This is likely but cannot be conﬁrmed from the
data reviewed here. If so, expansion of existing
management strategies, and coordination of
novel strategies, acrossthe region, would probably
be relatively successful and relatively cost-
effective. The likely contribution made by over-
weight/obesity to the diabetes problem in the
GCC region is suitable for management, at least
in part, by primary preventative measures,
which we anticipate would also be relatively
cost-effective.
Limitations of study
We report above that individual studies included
in our review demonstrated recent temporal
trends in prevalence of overweight and obesity,
even though this was not clear from our overview
of studies. This is probably illustrative of the
general heterogeneity of the reviewed studies.
The studies reviewed were relatively few and dis-
tributed across many years. They were of varied
population characteristics, in different regions of
six countries, and the utilized deﬁnitions of par-
ticular risk factors were inconsistent. We were
thus able to make only relatively crude obser-
vation, and could not provide measures of conﬁ-
dence in our outcomes. The quality of reporting
of results in the examined studies was also vari-
able. For example, many studies did not report
conﬁdence intervals or had missing data for key
J R Soc Med Sh Rep 2011;2:55. DOI 10.1258/shorts.2011.011019
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13variables. This reinforces the need for authors of
risk factors studies to use standard methods for
reporting the results such as STROBE guidelines.
Although quality was variable, it was never
alone a reason for exclusion. Quality was, rather,
incorporated into building our estimations of
ranges for normal versus abnormal among the
results returned. This was difﬁcult due to the
wide variability in these results, and the potential
for bias has implications for the strength of our
proposals. In addition, we may have increased
bias by duplication of included data, as it is antici-
pated that the female sample of one Al-Isa study
47
is that included in the mixed sample of another,
48
and the male sample of Jackson et al.
49 that
included in the sample of Jackson et al.
50 Finally,
all of our reviewed studies were published in
English, although we had no language restriction.
Hence, we may have limited capture of publi-
cations in other languages due to the databases
we searched.
Conclusions
Prevalence of overweight and obesity in the GCC
region is high and the ages of those affected
suggest it may be a relatively important factor in
the growing diabetes burden in this region.
Further studyaimed at elucidating its relative con-
tribution to the diabetes problem is desirable, but
regardless the reviewed data are suggestive that
implementation and enhancement of primary pre-
ventative strategies in particular would be useful
in the management of type 2 diabetes in the
GCC region. The current prevalences of hyperten-
sion and dyslipidaemia are unclear, but poten-
tially relatively high compared to many other
parts of the world. More comprehensive study of
their prevalence is desirable, and standardization
of deﬁnitions of these conditions will be important
if further study is to be maximally useful. Primary
preventative strategies may also be useful in
managing these conditions.
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